Anúncio
Anúncio

PRCT

PRCT logo

PROCEPT BioRobotics Corporation Common Stock

34.48
USD
Patrocinado
+0.56
+1.67%
08 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

35.13

+0.65
+1.87%

Relatórios de Lucros PRCT

Rácio de surpresa positiva

PRCT separação 10 de 17 últimas estimativas.

59%

Próximo Relatório

Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$96.02M
/
-$0.33
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+15.23%
/
-13.16%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+40.72%
/
-5.71%

PROCEPT BioRobotics Corporation Common Stock earnings per share and revenue

On 04 de nov. de 2025, PRCT reported earnings of -0.38 USD per share (EPS) for Q3 25, beating the estimate of -0.41 USD, resulting in a 9.48% surprise. Revenue reached 83.33 milhão, compared to an expected 82.56 milhão, with a 0.93% difference. The market reacted with a -9.74% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of -0.33 USD, with revenue projected to reach 96.02 milhão USD, implying an diminuir of -13.16% EPS, and aumentar of 15.23% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, PROCEPT BioRobotics Corporation Common Stock reported EPS of -$0.38, beating estimates by 9.48%, and revenue of $83.33M, 0.93% above expectations.
The stock price moved down -9.74%, changed from $35.02 before the earnings release to $31.61 the day after.
The next earning report is scheduled for 23 de fev. de 2026.
Based on 16 analistas, PROCEPT BioRobotics Corporation Common Stock is expected to report EPS of -$0.33 and revenue of $96.02M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio